Alliance for mRNA Medicines
Become a Member

Franklin Biolabs

Vatsala Naageshwaran, M.S., P.h.D.

Chief Executive Officer
Franklin Biolabs
  • Franklin Biolabs is a spinout from the gene therapy program at the University of Pennsylvania with a long track record of advancing the development and regulatory approval of genetic medicines.
  • As a center of excellence, Franklin Biolabs brings deep expertise in preclinical and translational models, as well as IND-enabling studies, supporting the safety, biodistribution, and pharmacology assessments required to accelerate mRNA therapeutics into the clinic.
  • In parallel with these preclinical programs, Franklin Biolabs provides integrated bioanalytical capabilities, including immunogenicity assessments, PK/PD and biomarker development, with assays that can be qualified and validated to support seamless progression from preclinical development through clinical studies and BLA submission.
  • Franklin Biolabs also enables the critical characterization of mRNA therapeutics through a comprehensive suite of analytical services, including platform, compendial, and product-specific assays designed to support quality control, product characterization, and regulatory readiness.